Navigation Links
Pro-Life Spokeswoman Objects to FDA Approval of 'Morning-After Pill' for Minors Without Prescription
Date:4/23/2009

WASHINGTON, April 23 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) announced late on April 22 that it has expanded over-the-counter access to the morning-after pill, Levonorgestrel or "Plan B," for 17-year-old minors as well as to adults. Deirdre McQuade, Assistant Director for Policy and Communications at the U.S. Conference of Catholic Bishops' Secretariat of Pro-Life Activities, objected to the move in the following statement:

"The FDA's court-driven decision to make Plan B available without a prescription to 17-year-old minors - as well as to adults - flies in the face of common sense. Levonorgestrel is a powerful drug, taken in two doses over a 12-hour period. It is 40 times more potent than comparable progestin-only birth control pills (Ovrette) for which a prescription is required.

"Wider access to Plan B could endanger the lives of newly-conceived children, and will put minors at risk for unnecessary side effects, undermine parental rights, and contribute to higher STD rates.

"Pregnancy is not a disease and fertility is not a pathological condition, so Plan B has no authentic therapeutic purpose, and can actually cause harm to women and their newly-conceived children.

"The FDA describes Plan B as 'a contraceptive drug.' Although Plan B can prevent fertilization, the manufacturer admits it may also prevent an embryo from implanting in the womb, which is essential to his or her continued survival. Since it takes several days for the growing embryo to reach the uterine lining and implant in the mother's womb, the child in his or her second week of life could die as a direct result of Plan B. This is properly understood as an early abortion.

"Without the benefit of a doctor's supervision, many teens will be unaware of this possible abortifacient action and the other risks posed by Levonorgestrel, particularly the risks from repeated use.'/>"/>

SOURCE U.S. Conference of Catholic Bishops, Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FRC Action: Obama Administration Working to Overturn Pro-Life Laws in Other Countries
2. Bishops Pro-Life Official Gravely Concerned Over Threat to HHS Conscience Protection Regulation
3. FRC Commends Effort to Protect Pro-Life Riders, Prevent Taxpayer Funded Abortions
4. Cardinal Rigali to Congress: Keep Existing Pro-Life Laws
5. Massive Nationwide Pro-Life Postcard Campaign Underway
6. President Obamas Reversal of Mexico City Policy Very Disappointing, Says Pro-Life Committee Chair
7. Blunt Marks Anniversary of Roe v. Wade, Signs Letter in Defense of Pro-Life Legislation
8. Pennsylvania Most Pro-Life State in America, California Least, According to Americans United for Life State Rankings
9. A.L.L. Personhood Conference Features Pro-Life New Media Stars
10. Pro-Life Chair to Congress: We Cant Reduce Abortions By Promoting Abortion
11. DNC Party Crashers: Police Arrest 1 Pro-lifer at Black Caucus; Eject Operation Rescue Leader from DNC Interfaith Gathering at Colorado Convention Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Narrow networks that vary ... employers effective options to trim pharmacy costs and ... they can enhance formulary compliance and achieve savings ... that nearly all PBMs now include a narrow ... The Aug. 12 webinar from Atlantic Information ...
(Date:8/1/2014)... 01, 2014 Millions of women suffer ... legs and in some cases the arms, causing an ... about 17 million women in the U.S. alone are ... with the pain, embarrassment and discomfort caused by lipedema, ... physicians are unaware that this is a disease,” says Dr. ...
(Date:8/1/2014)... August 01, 2014 Get the report ... with PitchBook presents the 3Q 2014 Private Equity Breakdown ... equity investment, exits and fundraising activity in the second ... help plan for private equity endeavors for the remainder ... to download it now. , About Merrill DataSite , ...
(Date:7/31/2014)... 31, 2014 The 2013 edition ... about chemical listings, appellate decisions, litigation and settlement ... affect compliance with California's Proposition 65. , The ... law, regulations, history and trends impacting California's Proposition ... installment of the series which adds approximately 200 ...
(Date:7/31/2014)... recently used birth control pills containing high-dose estrogen and ... breast cancer, whereas women using some other formulations did ... , a journal of the American Association for Cancer ... oral contraceptives [birth control pills] in the past year ... to never or former oral contraceptive use, and that ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services Webinar to Offer Health Plan, Employer Strategies for Implementing Narrow Pharma Networks 2Health News:Lipedema Centers Works With Insurers To Gain Coverage For Lipedema Treatment 2Health News:Register to Download Merrill DataSite's Report: PitchBook 3Q 2014 Private Equity Breakdown Report 2Health News:Save 25% on the Proposition 65 Handbook - 2013 Edition Through August 31 2Health News:Recent use of some birth control pills may increase breast cancer risk 2
... , WHEATON, Ill., Nov. 24 Dr. Nelson Escobar, ... the recipient of the James Brady Award. The award ... of Illinois during their annual conference on October 30, 2009. ... was given the award in recognition of his expertise in ...
... The Union Labor Life Insurance Company ("Union Labor Life") ... nation,s largest vision benefits and services company, to provide a ... union employers and their members. , VSP has 40,000 doctor ... of optical frames and more. "We understand how important quality ...
... Nov. 24 Centene Corporation (NYSE: CNC ... has selected Centene as one of two Coordinated Care ... (MississippiCAN), a coordinated care program for Mississippi Medicaid beneficiaries. ... a contract in which the company will serve eligible ...
... that pose choking hazard, are too loud, or contain dangerous ... holiday shopping season begins, parents need to know that many ... United States. , That,s the conclusion of the 24th annual ... U.S. Public Interest Research Group (PIRG). , The report focuses ...
... and low-volume centers, study found , TUESDAY, Nov. 24 ... angioplasties necessarily produce the best results for patients? Maybe ... perfect" when it comes to artery-opening procedures, but a ... high-volume hospitals performing more or less equally. , The ...
... have found that hormones produced during pregnancy induce a ... This protein, alpha-fetoprotein (AFP), may serve as a viable, ... cancer, according to findings published in Cancer Prevention ... Cancer Research. "Hormones in pregnancy, such as ...
Cached Medicine News:Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Protein from pregnancy hormone may prevent breast cancer 2
(Date:7/31/2014)... DIEGO, July 31, 2014 Tandem Diabetes Care®, Inc. ... manufacturer of the t:slim® Insulin Pump, today reported its financial ... In comparing the second quarter of 2014 to the ... to $10.3 million from $5.5 million , t:slim Pump ... In comparing six months ended June 30, 2014 ...
(Date:7/31/2014)... July 31, 2014 Nektar Therapeutics (Nasdaq: ... quarter ended June 30, 2014. Cash and ... million as compared to $309.1 million at March 31, 2014."The ... Nektar as we look forward to significant milestones for a ... President and Chief Executive Officer of Nektar. "The first of ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek Pharmaceuticals, ... it has initiated the development of its lead molecule, ... that it has selected Quotient Clinical, The Translational Pharmaceutics ... (UK) to run its early development programs. ... Application (CTA) by the end of the third quarter ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4
... SUNNYVALE, Calif., Feb. 28, 2011 /PRNewswire/ ... company developing innovative technologies in diabetes management, announced that ... Silicon Valley Bank and ... used to help complete clinical trials and commercialize POGO™, ...
... Feb. 28, 2011 Advanced Cell Diagnostics, Inc. ... study utilizing RNAscope™ technology to detect human papillomavirus ... head and neck cancer. HPV status determined by ... patient outcome and highly concordant with that determined ...
Cached Medicine Technology:Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation 2Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation 3ACD Announces Clinical Study Results Using its RNAscope™ Technology 2ACD Announces Clinical Study Results Using its RNAscope™ Technology 3
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Representing the next step in the evolution of point-of-care testing, the i-STAT 1 Analyzer uses one platform to perform glucose strip testing along with all i-STAT test cartridges....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
... bright xenon illumination for ... other instruments. Port allows ... optic cables. Worldwide voltage ... lamp change drawer ...
Medicine Products: